Compare Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) vs Zillow Group Inc Class A (ZG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Maravai LifeSciences Holdings Inc. Class A Common Stock vs Zillow Group Inc Class A — how do they compare? Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $977.37M), while Zillow Group Inc Class A trades at $29.49 (market cap $6.42B). The key difference: Zillow Group Inc Class A is far larger — about 6.6× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and Maravai LifeSciences Holdings Inc. Class A Common Stock is trading nearer its 52-week high, Zillow Group Inc Class A nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days and Zillow Group Inc Class A for 86 Days on average.
| MRVI | ZG | |
|---|---|---|
Market Cap | $977.37M | $6.42B |
Volume | 2,742,564 | 1,301,685 |
Sector | Health | Media |
52-Week High | $9.00 | $74.58 |
52-Week Low | $2.83 | $27.70 |
Typical Hold Time | 0 Days | 86 Days |
Enterprise Value | $1.08B | $6.29B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
Zillow Group (ZG) trades at $28.85, up 0.56% on the day, amid a bearish technical signal but with improving fundamentals. The company reported a return to profitability in 2025 with net income of $23 million (source: company earnings, 2025), and revenue growth is projected to continue. Recent news highlights AI integration in real estate and shifting housing market dynamics. Analyst consensus is a 'Hold' with a $48.60 price target, suggesting significant potential upside from current levels.
The outlook is cautiously optimistic. The primary opportunity lies in the substantial gap between the current price and the analyst target, coupled with revenue growth and a strategic pivot. Key risks include persistent housing market affordability headwinds, competitive pressures, and the stock's high P/E ratio of 127.3, which demands sustained earnings growth to justify.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Maravai LifeSciences Holdings Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →About Zillow Group Inc Class A
Zillow Group is an Internet-based real estate company that has historically focused on deriving ad revenue from third-party brokers on online marketplaces such as Zillow.com, Trulia, and HotPads. More recently it has shifted its focus to iBuying via the Zillow Offers platform.
Read more on ZG →
